XDx’s AlloMap Assay Included in New Organ-Transplant Guidelines

According to the guidelines, the qRT-PCR-based test "can … rule out the presence of acute cellular rejection of grade 2R or greater in appropriate low-risk patients, between six months and five years after heart transplantation."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.